Article Versions Notes

Mazorra Z, Cáceres-Lavernia HH, Nenínger-Vinageras E, Varona-Rodríguez LM, Viada CE, González Z, Rodríguez-Zhurbenko N, Thierry A-C, Suarez-Formigo GM, Ventura-Carmenate Y, et al. Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine: Immune Correlates in Long-Term Survivors. Biomedicines. 2025; 13(5):1122. https://doi.org/10.3390/biomedicines13051122

Mazorra, Zaima, Haslen H. Cáceres-Lavernia, Elia Nenínger-Vinageras, Leslie M. Varona-Rodríguez, Carmen Elena Viada, Zuyen González, Nely Rodríguez-Zhurbenko, Anne-Christine Thierry, Gisela María Suarez-Formigo, Yendry Ventura-Carmenate, and et al. 2025. "Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine: Immune Correlates in Long-Term Survivors" Biomedicines 13, no. 5: 1122. https://doi.org/10.3390/biomedicines13051122

Mazorra, Z., Cáceres-Lavernia, H. H., Nenínger-Vinageras, E., Varona-Rodríguez, L. M., Viada, C. E., González, Z., Rodríguez-Zhurbenko, N., Thierry, A.-C., Suarez-Formigo, G. M., Ventura-Carmenate, Y., Baumgaertner, P., Trabanelli, S., Jandus, C., & Crombet, T. (2025). Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine: Immune Correlates in Long-Term Survivors. Biomedicines, 13(5), 1122. https://doi.org/10.3390/biomedicines13051122